In focus · trending topic

Resokine

8 stories · following the connections

aTyr Pharma Provides Mechanistic Update on Resokine Pathway at American Academy of Immunology Annual Meeting

By Nasdaq OMXMay 2, 2018, 12:01 PM UTC

aTyr Pharma Doses First Subjects in Phase 1 Trial of iMod.Fc (ATYR1923)

By Nasdaq OMXNov 27, 2017, 1:01 PM UTC

aTyr Pharma Announces Third Quarter 2017 Operating Results and Provides Corporate Update

By Nasdaq OMXNov 14, 2017, 9:06 PM UTC

aTyr Pharma to Present Final Data for Resolaris Phase 1b/2 Trial in Patients with Early-Onset Facioscapulohumeral Muscular Dystrophy at the 22nd International Annual Congress of the World Muscle Society

By Nasdaq OMXSep 27, 2017, 12:01 PM UTC

aTyr Pharma to Present at Two Upcoming Investor Conferences in September

By Nasdaq OMXSep 6, 2017, 3:00 AM UTC

aTyr Pharma Announces $45 Million Equity Financing

By Nasdaq OMXAug 28, 2017, 11:30 AM UTC

aTyr Pharma Announces First Quarter 2017 Operating Results

By Nasdaq OMXMay 11, 2017, 8:06 PM UTC

aTyr Pharma Announces First Quarter 2017 Operating Results

By Nasdaq OMXMay 11, 2017, 8:06 PM UTC